Benefits
Supports Hair, Skin, and Nail Health
Biotin strengthens keratin, a protein in hair, skin, and nails, potentially reducing brittleness and promoting growth, though evidence is stronger for deficiency cases.
Aids Energy Metabolism
It helps convert carbohydrates, fats, and proteins into energy, supporting cellular function.
Regulates Blood Sugar
Biotin may improve glucose metabolism, potentially benefiting those with diabetes, though studies are mixed.
Supports Nervous System
It contributes to neurotransmitter activity and nerve health, aiding overall neurological function.
Pregnancy and Fetal Development
Adequate biotin is crucial during pregnancy to support embryonic growth and prevent developmental issues.
Mechanism of action
Cofactor for Carboxylase Enzymes
Biotin is covalently bound to five key carboxylase enzymes: Pyruvate carboxylase, Propionyl-CoA carboxylase, Methylcrotonyl-CoA carboxylase, Acetyl-CoA carboxylase 1 and Acetyl-CoA carboxylase 2. These enzymes catalyze carboxylation reactions, transferring a carboxyl group (CO₂) to substrates, which is critical for metabolic pathways.
Activation via Holocarboxylase Synthetase
Biotin is attached to a lysine residue on these enzymes by the enzyme holocarboxylase synthetase (HCS), forming a biotinylated holoenzyme. This biotinylation is essential for the enzyme's catalytic activity. The biotin molecule acts as a swinging arm, facilitating the transfer of CO₂ from bicarbonate to the substrate.
Gluconeogenesis and Krebs Cycle
Pyruvate carboxylase converts pyruvate to oxaloacetate, a precursor for glucose synthesis and an intermediate in the citric acid cycle.
Fatty Acid Synthesis
Acetyl-CoA carboxylase (1 and 2) catalyzes the formation of malonyl-CoA, a key step in fatty acid biosynthesis and regulation of mitochondrial fatty acid oxidation.
Amino Acid Catabolism
Propionyl-CoA carboxylase and methylcrotonyl-CoA carboxylase are involved in the breakdown of branched-chain amino acids (e.g., leucine, isoleucine) and odd-chain fatty acids.
Energy Metabolism
These carboxylation reactions support energy production and biosynthetic processes by feeding intermediates into central metabolic pathways.
Biotin Cycle and Recycling
Biotin is recycled through the action of biotinidase, which cleaves biotin from biocytin (biotin-lysine complex) or biotinylated peptides during protein turnover, making it available for reuse by HCS. This recycling ensures a steady supply of biotin for carboxylase activity, even with low dietary intake.
Non-Enzymatic Roles (Emerging Evidence)
Biotin may influence gene expression by modifying histones through biotinylation, mediated by HCS or biotinidase, affecting chromatin structure and gene regulation. It may also play a role in cell signaling and immune function, though these mechanisms are less well-established.
Clinical trials
Randomized, placebo-controlled, double-blind study at one U.S. clinical site evaluating an oral supplement (Viviscal®, containing marine protein complex AminoMar® plus biotin and other nutrients) in 60 healthy women aged 21-75 with self-perceived hair thinning. (Ablon 2012, J Clin Aesthet Dermatol)
60 women with self-perceived hair thinning. 90-day intervention.
Active group showed significant increase in number of terminal hairs in target area at day 90 vs placebo (p<0.0001). Note: this trial evaluated a multi-ingredient product, not biotin in isolation. The biotin contribution cannot be isolated from marine protein complex effect. Industry-funded.
Systematic review of biotin supplementation for hair and nail growth, conducted via PubMed search of clinical trials and case reports. Outcome: efficacy of biotin in non-deficient populations. (Patel et al. 2017, Skin Appendage Disord)
Pooled across 18 cases of biotin use for hair/nails.
All cases with positive outcomes had documented or strongly suspected biotin deficiency or genetic biotin metabolism disorders. Authors found no high-quality evidence supporting biotin supplementation for hair growth in healthy, non-deficient individuals. Suggests biotin works only when treating actual deficiency — not as general hair growth supplement. Despite this, marketed claims often overstate evidence.
Case series of three children with familial uncombable hair syndrome (a rare hair shaft disorder) treated with biotin supplementation. Hair texture, manageability, and microscopic structure assessed pre/post. (Boccaletti et al. 2007, Pediatr Dermatol)
3 children with uncombable hair syndrome.
Improvement in hair manageability after biotin supplementation in all three cases. Note: This is a rare syndrome, not a model for general hair issues. The improvement supports biotin's role in hair shaft formation when there's a relevant genetic disorder. Single case series — not generalizable.
Case report of an infant developing biotin deficiency after consumption of a biotin-free amino acid formula. Clinical signs included alopecia, dermatitis, and metabolic acidosis. (Mock et al. 2005)
Single infant case.
Biotin deficiency manifested as hair loss, scaly dermatitis, and metabolic abnormalities. Resolved with biotin supplementation. Demonstrates the syndromic presentation of biotin deficiency. Note: dietary biotin deficiency is rare in normal populations — pregnant women, those on long-term anticonvulsants, or with biotin-resistant biotinidase deficiency are at higher risk.
Non-randomized, uncontrolled pilot study in 23 patients with progressive multiple sclerosis receiving 100-300 mg/day biotin (~10,000× RDA). Outcomes: clinical disability, ambulation, visual function. (Sedel et al. 2015, Mult Scler Relat Disord)
23 progressive MS patients. Open-label.
Initial pilot suggested clinical improvement in some patients. Note: this triggered the larger MD1003 (high-dose biotin) program. Subsequent Phase 3 RCTs (SPI2 trial, 2020) FAILED to show benefit on the primary endpoint, leading to discontinuation of the program. The early pilot data turned out NOT to translate to controlled trials. High-dose biotin can also cause CRITICAL lab interference with thyroid, troponin, and hormone immunoassays — not used clinically for MS.
Uncontrolled trial in 35 women with brittle fingernails receiving biotin (2.5 mg/day) for 6-15 months. Outcomes: nail thickness (scanning electron microscopy), patient-reported brittleness. (Colombo et al. 1990; or Hochman 1993 case series)
35 women with onychoschizia/brittle nails. 6-15 months.
63% showed clinical improvement in nail strength and reduced splitting. Microscopy showed increased nail thickness. Note: uncontrolled design — without placebo, regression to the mean and natural variation in nail growth cannot be excluded. Modern dermatology guidelines describe this evidence as supportive but not definitive.
Systematic review and meta-analysis of randomized controlled trials evaluating biotin supplementation effects on glycemic control (FPG, HbA1c) and lipid profile in patients with type 2 diabetes. (2022, J Diet Suppl)
Pooled across multiple RCTs.
Biotin supplementation modestly reduced fasting glucose and triglycerides in T2DM patients vs control. Effects on HbA1c less consistent. Mechanism may involve enhanced insulin secretion and/or pyruvate carboxylase activity. Effect sizes generally small; biotin is not a substitute for established diabetes therapies.